Royalty Pharma Declares $0.235 Fourth-Quarter 2026 Dividend

Royalty Pharma’s board approved a $0.235 dividend per Class A ordinary share for the fourth quarter of 2026. Payment is scheduled for December 10, 2026, to shareholders of record at the close of business on a date not specified in the supplied text.